Barbara Klencke's Insider Trades & SAST Disclosures
Barbara Klencke's most recent trade in Alx Oncology Holdings Inc was a trade of 40,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barbara Klencke.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Tscan Therapeutics Inc | Barbara Klencke | Director | Purchase of securities on an exchange or from another person at price $ 5.29 per share. | 23 Sep 2024 | 5,000 | 45,000 | - | 5.3 | 26,450 | Voting Common Stock |
| Tscan Therapeutics Inc | Barbara Klencke | Director | Purchase of securities on an exchange or from another person at price $ 5.69 per share. | 23 Aug 2024 | 5,000 | 35,000 | - | 5.7 | 28,450 | Voting Common Stock |
| Tscan Therapeutics Inc | Barbara Klencke | Director | Purchase of securities on an exchange or from another person at price $ 5.53 per share. | 23 Aug 2024 | 5,000 | 40,000 | - | 5.5 | 27,650 | Voting Common Stock |
| Xencor Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,971 | 11,971 | - | - | Stock Option (Right to Buy) | |
| Xencor Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,986 | 5,986 (0%) | 0% | 0 | Common Stock | |
| eFFECTOR Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 800 | 800 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 47,500 | 47,500 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Klencke Barbara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 2,000 | 2,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Klencke Barbara | Director | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 14 Dec 2023 | 5,000 | 30,000 | - | 5.1 | 25,400 | Voting Common Stock |
| Xencor Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2023 | 40,070 | 40,070 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 36,524 | 36,524 | - | - | Stock Option (Right to Buy) | |
| Tscan Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 9,146 | 9,146 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 28,125 | 28,125 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges